Exjade and Glucophage drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exjade (deferasirox) and Glucophage (metformin hydrochloride). Common drug interactions include nausea among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Exjade and Glucophage. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Exjade?

Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.

What is Glucophage?

Glucophage has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 60,851 Glucophage users. Check the latest studies of Glucophage.



On Jul, 14, 2026

62 people who take Exjade and Glucophage together, and have interactions are studied.

Exjade and Glucophage drug interactions.

What are the common drug interactions of Exjade and Glucophage, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Muscular weakness (muscle weakness)
  6. Myalgia (muscle pain)
  7. Asthenia (weakness)
  8. Circulatory collapse
  9. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  10. Escherichia sepsis (bacterial infection by escherichia coli)

male:

  1. Pyrexia (fever)
  2. Death
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Serum ferritin increased
  5. Back pain
  6. Splenomegaly (enlargement of spleen)
  7. Anaemia (lack of blood)
  8. Dyspnoea (difficult or laboured respiration)
  9. Fatigue (feeling of tiredness)
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

What are the common drug interactions of Exjade and Glucophage, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Back pain
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Haemoglobin decreased
  4. Pallor
  5. Platelet count increased
  6. Renal injury (kidney injury)
  7. Serum ferritin increased
  8. White blood cell count increased

20-29:

n/a

30-39:

  1. Death
  2. Abdominal pain
  3. Anxiety
  4. Back pain
  5. Blood alkaline phosphatase increased
  6. Blood glucose increased
  7. Blood urea increased
  8. Diarrhoea
  9. Nausea (feeling of having an urge to vomit)
  10. Nervousness

40-49:

  1. Acute leukaemia (blood cancer)
  2. Rash
  3. Asthenia (weakness)
  4. Death
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Fatigue (feeling of tiredness)
  7. Iron binding capacity total decreased
  8. Lung disorder (lung disease)
  9. Serum ferritin increased

50-59:

  1. Hepatitis (inflammation of the liver)
  2. Hyperbilirubinaemia (excess of bilirubin in the blood)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Peripheral coldness
  5. Pyrexia (fever)
  6. Splenomegaly (enlargement of spleen)
  7. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups)
  8. Muscular weakness (muscle weakness)
  9. Myalgia (muscle pain)
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

60+:

  1. Pyrexia (fever)
  2. Diarrhoea
  3. Dyspnoea (difficult or laboured respiration)
  4. Escherichia sepsis (bacterial infection by escherichia coli)
  5. Headache (pain in head)
  6. Pneumonia
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Cellulitis (infection under the skin)
  9. Circulatory collapse
  10. Disseminated intravascular coagulation (systemic activation of blood coagulation)

What are the existing conditions these people have? *

  1. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 20 people, 32.26%
  2. High Blood Pressure: 6 people, 9.68%
  3. Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 6 people, 9.68%
  4. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 5 people, 8.06%

* Approximation only. Some reports may have incomplete information.

Do you take Exjade and Glucophage?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exjade and Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exjade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucophage and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on deferasirox and metformin hydrochloride (the active ingredients of Exjade and Glucophage, respectively), and Exjade and Glucophage (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: